BURJEEL Share Price Performance
د.إ1.32
-0.90 (-40.54%)
54.2% undervalued intrinsic discount
د.إ2.88
Fair Value
Price د.إ1.32
AnalystHighTarget د.إ2.88
AnalystConsensusTarget د.إ1.69
AnalystLowTarget د.إ1.50
Fair Valueد.إ2.88
Share Pricen/a
Burjeel Holdings PLC Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 26 Fair Values set on narratives written by author
BURJEEL Community Narratives
AN
Fair Value د.إ2.88 54.2% undervalued intrinsic discount
Rising Health Awareness And Telemedicine Will Expand MENA Healthcare
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
Fair Value د.إ1.69 n/aintrinsic discount
BURJEEL: Rising Profit Margins Will Drive Share Gains Amid Index Removal
0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
AN
Fair Value د.إ1.5 12.0% undervalued intrinsic discount
GCC Healthcare Will Suffer Margin Erosion Amid Regulatory Pressures
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
BURJEEL: Rising Profit Margins Will Drive Share Gains Amid Index Removal
Key Takeaways Expansion into high-value medical specialties and new geographies supports revenue growth, margin improvement, and diversification of patient base. Investments in digital health, asset optimization, and operational efficiency drive profitability, operational flexibility, and long-term earnings stability.Read more
0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
AN
د.إ1.69
n/aintrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
9.98% p.a.
Profit Margin
9.92%
Future PE
20.82x
Share price in 2028
د.إ2.85
Rising Health Awareness And Telemedicine Will Expand MENA Healthcare
Key Takeaways Rapid expansion in high-growth specialties and mental health is unlocking new high-margin revenue streams and driving faster-than-expected profit growth. Asset-light international partnerships and advanced healthcare technology investments are structurally improving efficiency, patient volumes, and long-term profitability.Read more
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
د.إ2.88
54.2% undervalued intrinsic discount
AnalystHighTarget Fair Value
Revenue growth
10.69% p.a.
Profit Margin
7.55%
Future PE
46.39x
Share price in 2028
د.إ4.84
GCC Healthcare Will Suffer Margin Erosion Amid Regulatory Pressures
Key Takeaways Heavy investment in new facilities and technology, along with strong competition and regional risks, could significantly limit future profitability and cash flow stability. Growing adoption of digital health and possible regulatory changes threaten traditional revenue streams and may undermine Burjeel's long-term competitive positioning.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
د.إ1.5
12.0% undervalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
10.33% p.a.
Profit Margin
7.55%
Future PE
20.8x
Share price in 2028
د.إ2.66
Snowflake Analysis
Burjeel Holdings PLC Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 11, 2026
- 0.077
- 30.29%
- 7.46%
- 87.7%
About BURJEEL
- Founded
- 2007
- Employees
- 13179
- CEO
- WebsiteView website
Burjeel Holdings PLC, together with its subsidiaries, owns and operates multi-specialty hospitals and medical centers in the United Arab Emirates, the Sultanate of Oman, and the Kingdom of Saudi Arabia. The company operates in four segments: Hospitals, Medical Centre, Pharmacies, and Others. It offers inpatient, day-care, and outpatient services to patients to diagnosis the disease, as well as medical and surgical treatment services; medical consultation, and lab and radiology diagnostic treatment services; and sells pharmaceutical goods, cosmetic products, and medical equipment. The company provides supply chain, valet parking, IT services, claim submission, and procurement services. It operates hospitals under the Burjeel, Medeor Hospital, LLH Hospital, Lifecare Hospitals, Tajmeel, and Physiotherabia brand names. The company was founded in 2007 and is headquartered in Abu Dhabi, the United Arab Emirates. Burjeel Holdings PLC is a subsidiary of Vps Healthcare Holdings Pvt. Ltd.
